| 000 | 01525 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512091737.0 | ||
| 264 | 0 | _c19750423 | |
| 008 | 197504s 0 0 eng d | ||
| 022 | _a0300-9718 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMálek, P | |
| 245 | 0 | 0 |
_aStudies on the therapeutic use of mercurascan (MSC). Part 2: Antiarrhythmogenic and haemodynamic effect of MSC in experimental myocardial ischaemia. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology, therapy and toxicology _cDec 1974 |
||
| 300 |
_a273-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aCardiac Complexes, Premature |
| 650 | 0 | 4 |
_aCoronary Vessels _xsurgery |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aElectrodes |
| 650 | 0 | 4 |
_aFluoresceins _xpharmacology |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHeart Conduction System _xdrug effects |
| 650 | 0 | 4 | _aLigation |
| 650 | 0 | 4 |
_aMercury _xpharmacology |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 | _aRefractory Period, Electrophysiological |
| 650 | 0 | 4 | _aTachycardia |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aVectorcardiography |
| 650 | 0 | 4 | _aVentricular Fibrillation |
| 700 | 1 | _aVrána, M | |
| 700 | 1 | _aKolc, J | |
| 700 | 1 | _aNetusil, M | |
| 700 | 1 | _aBlazek, Z | |
| 773 | 0 |
_tInternational journal of clinical pharmacology, therapy and toxicology _gvol. 10 _gno. 4 _gp. 273-82 |
|
| 999 |
_c4146383 _d4146383 |
||